What is the current Price Target for the Cingulate stock?

The average Cingulate target price is $20.40. This is 322.36% higher than the current stock price. The highest price target is 856.52%, the lowest is 67.29%. 7 Analysts have issued a price target Cingulate 2027 .

How high will the Cingulate stock rise?

No reliable answer can be given as to how high the Cingulate stock will rise. The performance of stocks, including the Cingulate stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Cingulate stock today?

The performance of Cingulate stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Cingulate stock fall?

The decline in Cingulate stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Cingulate Forecast, price target & analysts

$4.83

4.55%

Nasdaq, Sep 25, 04:00 pm EDT. Closed.

ISIN

US17248W3034

Symbol

CING

Reports

Quarter | Annual

Sector

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Pharmaceuticals

Overview Analysts Charts Ownership News Strategies

Cingulate Target price 2026 - Analyst rating & recommendation

Cingulate Classifications & Recommendation

Buy

90%

Hold

10%

Cingulate Price Target

Target Price	$20.40
Price	$4.83
Potential	322.36% register free of charge
Number of Estimates	7

	7 Analysts have issued a price target Cingulate 2027 . The average Cingulate target price is $20.40. This is 322.36% register free of charge higher than the current stock price. The highest price target is $46.20 856.52% register free of charge , the lowest is $8.08 67.29% register free of charge .
	A rating was issued by 10 analysts: 9 Analysts recommend Cingulate to buy, 1 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Cingulate stock has an average upside potential 2027 of 322.36% register free of charge . Most analysts recommend the Cingulate stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 & 2028

Create a premium account to unlock analyst estimates. Learn more

Annually

	Dec '25	2026 Estimates
Earnings Per Share $	-4.44	-2.35
	59.12%	47.07%
P/E		negative
EV/Sales		15.89

8 Analysts have issued a Cingulate forecast for earnings per share. The average Cingulate EPS is

unlock

. This is

unlock

than earnings per share in the financial year 2025. The highest EPS forecast is

unlock

, the lowest is

unlock

This results in the following potential growth metrics and future valuations:

2025	$-4.44	59.12%
2026	$-2.35 47.07% unlock
2027	$-1.93 17.87% unlock
2028	$-1.13 41.45% unlock

Current	-2.22	155.99%
2026	-2.05 7.47% unlock
2027	-2.50 21.95% unlock
2028	-4.27 70.80% unlock

Cingulate...

Current Cingulate Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
Roth Capital	Locked ➜ Locked	Locked	Aug 24 2026
Ascendiant Capital	Locked ➜ Locked	Locked	Aug 20 2026
Ascendiant Capital	Locked ➜ Locked	Locked	Jun 08 2026
HC Wainwright & Co.	Locked ➜ Locked	Locked	May 26 2026
Ascendiant Capital	Locked ➜ Locked	Locked	Apr 08 2026
Roth Capital	Locked ➜ Locked	Locked	Mar 23 2026
Ascendiant Capital	Locked ➜ Locked	Locked	Dec 08 2025

Analyst Rating	Date
Locked Roth Capital: Locked ➜ Locked	Aug 24 2026
Locked Ascendiant Capital: Locked ➜ Locked	Aug 20 2026
Locked Ascendiant Capital: Locked ➜ Locked	Jun 08 2026
Locked HC Wainwright & Co.: Locked ➜ Locked	May 26 2026
Locked Ascendiant Capital: Locked ➜ Locked	Apr 08 2026
Locked Roth Capital: Locked ➜ Locked	Mar 23 2026
Locked Ascendiant Capital: Locked ➜ Locked	Dec 08 2025

Discover more stocks with a high price target

NIO ADR 104.57%

Alibaba Group Holding Ltd 70.15%

Rheinmetall 66.12%

Infineon 62.78%

Tencent Holdings Ltd. 56.53%

Adyen 53.79%

TUI 52.57%

Uber Technologies 47.97%

BYD 47.08%

Siemens Energy 46.63%

Adidas 42.38%

Deutsche Telekom 37.89%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now